Nutlin 3 | List of Frontiers open access articles

Original Research

Published on 10 Jul 2015

The use of ion mobility mass spectrometry to probe modulation of the structure of p53 and of MDM2 by small molecule inhibitors

in Structural Biology

Eleanor Rose Dickinson
Ewa Jurneczko
Judith Nicholson
Ted Hupp
Joanna Zawacka-Pankau
Galina Selivanova
Perdita Elizabeth Barran

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2015.00039

7,026 views
33 citations

Perspective

Published on 20 May 2022

Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19

in Pharmacology of Infectious Diseases

Barbara Bortot
Arianna Romani
Giuseppe Ricci
Stefania Biffi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.877422

3,312 views
6 citations

Review

Published on 06 Jan 2022

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments

in Head and Neck Cancer

Tycho de Bakker
Fabrice Journe
Géraldine Descamps
Sven Saussez
Tatiana Dragan
Ghanem Ghanem
Mohammad Krayem
Dirk Van Gestel

Frontiers in Oncology

doi 10.3389/fonc.2021.799993

18,129 views
60 citations

Original Research

Published on 13 Dec 2022

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells

in Pharmacology of Infectious Diseases

Giada Lodi
Valentina Gentili
Fabio Casciano
Arianna Romani
Giorgio Zauli
Paola Secchiero
Enrico Zauli
Carolina Simioni
Silvia Beltrami
Mercedes Fernandez

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1018761

5,287 views
11 citations

Original Research

Published on 10 Feb 2022

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy

in Molecular and Cellular Pathology

Weili Li
Xiaoping Wang
Tianhua Liu
Qian Zhang
Jing Cao
Yanyan Jiang
Qianbin Sun
Chun Li
Wei Wang
Yong Wang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2022.813370

8,200 views
29 citations

Review

Published on 14 Jul 2022

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation

in Ophthalmology

Giorgio Zauli
Sara AlHilali
Samar Al-Swailem
Paola Secchiero
Rebecca Voltan

Frontiers in Medicine

doi 10.3389/fmed.2022.902713

4,519 views
9 citations

Original Research

Published on 24 Jun 2025

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

in Molecular and Cellular Oncology

Xiao Liu
Honglin Qu
Jingmin Li
Xuhong Sun
Zhenlin Wang
Dong Wang
Xianyong Bai
Xiaoyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584811

4,449 views
3 citations

Original Research

Published on 05 Oct 2017

PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients

in Alzheimer's Disease and Related Dementias

Felipe Salech
Daniela P. Ponce
Carol D. SanMartín
Nicole K. Rogers
Carlos Chacón
Mauricio Henríquez
Maria I. Behrens

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2017.00310

5,143 views
28 citations

Articles

The use of ion mobility mass spectrometry to probe modulation of the structure of p53 and of MDM2 by small molecule inhibitors

Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients